Milde, T., Lodrini, M., Korshunov, A., Kool, M., Pfister, S., Kulozik, A., . . . Deubzer, H. (2012). HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment. Journal of neuro-oncology, 110(3), . https://doi.org/10.1007/s11060-012-0978-1
Chicago-Zitierstil (17. Ausg.)Milde, Till, Marco Lodrini, Andrey Korshunov, Marcel Kool, Stefan Pfister, Andreas Kulozik, Olaf Witt, und Hedwig Deubzer. "HD-MB03 Is a Novel Group 3 Medulloblastoma Model Demonstrating Sensitivity to Histone Deacetylase Inhibitor Treatment." Journal of Neuro-oncology 110, no. 3 (2012). https://doi.org/10.1007/s11060-012-0978-1.
MLA-Zitierstil (9. Ausg.)Milde, Till, et al. "HD-MB03 Is a Novel Group 3 Medulloblastoma Model Demonstrating Sensitivity to Histone Deacetylase Inhibitor Treatment." Journal of Neuro-oncology, vol. 110, no. 3, 2012, https://doi.org/10.1007/s11060-012-0978-1.